Skip to main content
. Author manuscript; available in PMC: 2013 Apr 2.
Published in final edited form as: Mol Pharm. 2012 Mar 16;9(4):996–1010. doi: 10.1021/mp300023x

Table 4.

Performance of the Bayesian classifiers for the WOMBAT-PK test set

Training set Test set

Thresholds Model Fingerprints TP FN FP TN SE SP PRE1 PRE2 GA C TP FN FP TN SE SP PRE1 PRE2 GA C
1µm BC-19 ECFC_8 106 28 54 532 0.791 0.908 0.663 0.950 0.886 0.654 13 6 7 40 0.684 0.851 0.650 0.870 0.803 0.527
5µm BC-20 FCFP_8 180 44 76 419 0.804 0.846 0.703 0.905 0.833 0.629 31 1 19 15 0.969 0.441 0.620 0.938 0.697 0.478
10µm BC-21 LCFC_6 240 39 101 339 0.860 0.770 0.704 0.897 0.805 0.615 42 3 10 11 0.933 0.524 0.808 0.786 0.803 0.521
20µm BC-22 LCFC_4 278 43 79 314 0.866 0.799 0.779 0.880 0.829 0.662 46 1 9 10 0.979 0.526 0.836 0.909 0.848 0.614
30µm BC-23 ECFC_4 279 65 48 321 0.811 0.870 0.853 0.832 0.842 0.683 52 1 6 7 0.981 0.538 0.897 0.875 0.894 0.633
40µm BC-24 ECFC_4 289 75 40 319 0.794 0.889 0.878 0.810 0.841 0.685 51 4 3 8 0.927 0.727 0.944 0.667 0.894 0.632
HHS Vulnerability Disclosure